Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2961
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49411
I'm sure that everyone understands that when
(6)
Drano
10/02/2018 10:09:00 AM
49410
You show a complete lack of understand. "Short"
(5)
Drano
10/02/2018 10:07:13 AM
49409
More distort... Shorts don't sell shares. They
(3)
bejamin
10/02/2018 10:01:35 AM
49408
Order filled at .195, thank you shorts! Go
(1)
AlanC
10/02/2018 9:54:42 AM
49407
I can't count how many tomes hindsight has kicked
(2)
BooDog
10/02/2018 8:24:04 AM
49406
I was being a little sarcastic... I'd be estatic
(2)
bejamin
10/02/2018 8:20:43 AM
49405
I can't afford to double down how much money I
(1)
BooDog
10/02/2018 8:17:51 AM
49404
I wish I could own 7billion shares like half the
(2)
bejamin
10/02/2018 8:03:49 AM
49403
I lowered to .151 before open yesterday. thought
(2)
BooDog
10/02/2018 5:48:26 AM
49402
26% marked today! Go IPIX!!!
(1)
AlanC
10/01/2018 5:37:09 PM
49401
Youre shoveling alright..but it aint
(5)
B.Izzy
10/01/2018 3:17:46 PM
49400
I saw where Novartis got BTD for Kisqali
(2)
smokenhot
10/01/2018 2:18:14 PM
49399
Dont sell, you wont lose a dime,
(1)
scgmck1
10/01/2018 1:54:34 PM
49398
Gosh guys, Squott thinks were out of dough and
(4)
scgmck1
10/01/2018 1:51:56 PM
49397
Sure hope you're right. Losing money faster than
Squar
10/01/2018 1:51:28 PM
49396
BTD alone takes IPIX over .50. Aspire deal still
(3)
smokenhot
10/01/2018 1:22:07 PM
49395
Is that so? What's going to turn this around
(2)
Squar
10/01/2018 12:46:52 PM
49394
More pure unadulterated bullshit from the cheap
(7)
scgmck1
10/01/2018 12:38:22 PM
49393
Thanks Sox. I always appreciate your insight.
Loose Lips
10/01/2018 12:27:30 PM
49392
No one but the stock price. You must have,gotten
(2)
Squar
10/01/2018 12:26:21 PM
49391
Really knocking it out of the
(2)
bejamin
10/01/2018 12:20:48 PM
49390
Check. Almost checkmate. No one's
(4)
BooDog
10/01/2018 10:30:46 AM
49389
I agree that IPIX longs will soon have lots to
AlanC
10/01/2018 8:45:32 AM
49388
retail can't .. but NR can slide via those t
(4)
4kids
10/01/2018 7:59:09 AM
49387
"You cannot trade OTC Bulletin Board securities
BooDog
10/01/2018 6:59:07 AM
49386
And the batteries are still bad. He's working on
incubus
09/30/2018 3:13:00 PM
49385
exactly but why it's worth noting the *math* in
(2)
4kids
09/30/2018 12:56:39 PM
49384
or to put it another way .. 2017 YTD Volume on
(4)
4kids
09/30/2018 12:53:55 PM
49383
And that is why there are now purportedly bullish
Drano
09/30/2018 12:51:10 PM
49382
folks always have to do what is best for
(8)
4kids
09/30/2018 11:58:13 AM
49381
I think what most troubles investors, outside of
(2)
Commando911
09/30/2018 11:42:49 AM
49380
Lovaza was the competitor by Glaxo. Its been a
(1)
NickAidenNY
09/30/2018 10:34:09 AM
49379
I am the one who brought up AMRN since I bought
(3)
NickAidenNY
09/30/2018 10:29:27 AM
49378
I know based on a PM I received some longs are
(2)
AlanC
09/30/2018 8:58:44 AM
49377
Posted this at the swamp which IMO has few posts
(3)
AlanC
09/30/2018 8:57:03 AM
49376
Great posts Mo but your #'s are quite "tame".
(4)
Kelt
09/29/2018 8:36:48 PM
49375
NOT GOING TO HAPPEN!!! Kelt
(2)
Kelt
09/29/2018 8:23:37 PM
49374
Everyone on a message board has an opinion. The
(5)
Mo
09/29/2018 7:21:57 PM
49373
Step 1: The milestone agreement in June was to
(7)
Mo
09/29/2018 7:21:24 PM
49372
Step 2 : Flush with cash from the Brilacidin deal
(6)
Mo
09/29/2018 7:20:46 PM
49371
Step 3: With Brilacidin and Prurisol now under
(7)
Mo
09/29/2018 7:19:55 PM
49370
Step 4 : Brilacidin and Prurisol have advanced
(8)
Mo
09/29/2018 7:19:12 PM
49369
Elon Musk's blabbermouth lies cost him 20 million
(2)
Drano
09/29/2018 6:06:07 PM
49367
SOX making sure the OM and UP patents are valid
(2)
smokenhot
09/29/2018 5:12:58 PM
49366
The only reason I feel they are more likely to
(2)
NickAidenNY
09/29/2018 4:52:09 PM
49365
A:Celgene is not a good example and B:I don't see
Kelt
09/29/2018 4:33:10 PM
49363
I feel the 10k broke out Keventrin specifically
(3)
NickAidenNY
09/29/2018 4:08:30 PM
49362
I will not agree or disagree with your theory as
(5)
Kelt
09/29/2018 3:42:58 PM
49361
Dr. Menon is in his mid-70's. He has done the
(2)
Drano
09/29/2018 3:42:17 PM
49360
I think Dr. Menons termination was to reduce
(2)
sox0407
09/29/2018 3:12:52 PM
Newer
Older
Recent Articles
Neuronetics Welcomes Steven Pfanstiel as CFO—A New Era Begins
S&P Global Partners with Anthropic to Transform Financial Analysis
SELLAS Advances SLS009 for First-Line AML Following Phase 2 Success
Maryland Court Decision Strengthens MSP Recovery's Case Against GEICO
Transformational Leadership Change at Neuronetics Strengthens Vision
Emergent BioSolutions Sets Date for Q2 Financial Call
Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results
Iovance Biotherapeutics Enhances Leadership with CFO Appointment
WestKam Gold Corp. Welcomes New Interim CFO and Funding Initiative
Changes to Synthetic Dyes in Ice Cream: Major Industry Impact
ProKidney and FDA Collaboration on Rilparencel Approval Insights
Mark Cuban Spotlights Political Strategies of Zohran Mamdani
Unlock Profits with AAS MINER's Smart Mining Innovation
BriaCell Expands Cancer Research Collaborations with Mayo Clinic
Abeona Therapeutics Expands Access to ZEVASKYN Gene Therapy
Mill Creek Residential Opens Modera St. Paul for New Residents
Nexxen Expands CTV Opportunities Through Partnership with VIDAA
Alidade Capital Expands Leadership in Net Lease Investments
Emergent BioSolutions Plans Q2 Financial Reporting Events
Rhode Island's New Law Shields Homeowners from Bad Contracts
Iovance Biotherapeutics Welcomes Corleen Roche as CFO
Insights on Trade Desk Inc and Other Market Movers Today
Sky Quarry Embarks on Innovative Digital Asset Strategy
Canada Nickel Unveils Promising Mineral Resource Estimates
Westgate Energy's Strategic Advances in Oil Production and Market Growth
Spectral Capital Expands Portfolio with 42 Telecom Acquisition
GIBO Holdings Innovates Monetization for Short-Drama Platforms
Palatin Advances Obesity Research with PL7737: Key Findings
Exciting New Bybit Promotion Offers 20,000 USDT Weekly Rewards
BlackRock Sees Significant Revenue Growth and AUM Increase
Innovative Partnership to Enhance Marine Retail Solutions
Breakthrough Advances in Weight Loss Solutions by Palatin
Western Copper and Gold's Essential ESE Project Update
Coveo's Strategic Moves: Renewing Your Investment Confidence
OSR Holdings Welcomes Dr. Niethammer as New CMO of Vaximm
PSEG To Share Insights on Q2 2025 Financial Performance
GIBO Click Achieves Milestone with DramaFlow Monetization Engine
Freightos Achieves Record Performance in Second Quarter
7-Eleven Unveils Flavorful New Menu for Summer Enjoyment
Mokas Coffee & Eatery Announces Exciting Franchise Plans
Rhode Island's New Law Shields Homebuyers from Unfair Practices
S&P Global and Anthropic Collaborate to Transform Financial Data Access
Eshbal Expands U.S. Market Reach with Strategic Moves
YMCA's Ongoing Recovery Empowered by Community Support
Navigating Uncertain Markets: Insights from M4Markets Podcast
Aurora Spine Engages at Prestigious Pain Management Conference
Maryland Court Victory Boosts MSP Recovery's Legal Efforts
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Therapy Development
Goodfood Market Corp to Announce Q3 Fiscal 2025 Results Soon
Flagship Communities REIT Declares July 2025 Cash Distribution